Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dipna Pharmachem Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dipna Pharmachem Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dipna Pharmachem - Board Meeting Outcome for Outcome Of Board Meeting

    12 Sep 2025, 5:01PM Outcome of Board Meeting
  • Dipna Pharmachem - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., Tuesday, 9Th September, 2025

    9 Sep 2025, 4:33PM Allotment of 2,98,74,000 Convertible Warrants pursuant to the preferential issue.
  • Dipna Pharmachem - Voting Results Of The Annual General Meeting

    1 Sep 2025, 6:34PM Voting Results of the Annual General Meeting held on 30th August, 2025.
  • Dipna Pharmachem - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Sep 2025, 6:23PM Scrutinizer Report of the Annual General Meeting held on 30th August, 2025.
  • Dipna Pharmachem - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Sep 2025, 6:23PM Scrutinizer Report of the Annual General Meeting held on 30th August, 2025.
  • Dipna Pharmachem - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Sep 2025, 6:23PM Scrutinizer Report of the Annual General Meeting held on 30th August, 2025.
  • Dipna Pharmachem - Intimation Of In-Principle Approval For Issue Of 7,66,05,000 Warrants Convertible Into Equity Shares Of M/

    30 Aug 2025, 11:54AM Intimation of In-principle approval in matter of issue of 7,66,05,000 warrants convertible into equity shares on preferential basis received from BSE
  • Dipna Pharmachem - Undertaking Regarding Appointment Of Monitoring Agency - Preferential Issue Of Equity Shares

    28 Aug 2025, 5:40PM Undertaking regarding Appointment of Monitoring Agency in matter of Preferential issue of Equity Shares of the Company
  • Dipna Pharmachem - Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requir

    8 Aug 2025, 6:48PM Intimation of Book Closure
  • Dipna Pharmachem - Reg. 34 (1) Annual Report.

    8 Aug 2025, 6:39PM Annual Report for Financial Year 2024-25
  • Dipna Pharmachem - Notice Of Annual General Meeting To Be Held On 30Th August, 2025

    8 Aug 2025, 6:36PM Intimation of Annual General Meeting to be held on 30th August, 2025
  • Dipna Pharmachem - Board Meeting Outcome for Outcome Of Board Meeting

    8 Aug 2025, 6:28PM Outcome of the Board Meeting held on 08-08-2025
  • Dipna Pharmachem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2025, 5:58PM Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018
  • Dipna Pharmachem - Outcome Of The Board Meeting

    7 Jul 2025, 8:26PM Outcome of the Board Meeting
  • Dipna Pharmachem - Integrated Filing (Finance)

    7 Jul 2025, 8:23PM Integrated Filing (Finance)
  • Dipna Pharmachem - Financial Results For Half Year And Year Ended On 31St March, 2025

    7 Jul 2025, 8:19PM Financial Results for Half year and Year Ended on 31st March, 2025
  • Dipna Pharmachem - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 7Th July, 2025

    7 Jul 2025, 8:14PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Director
  • Dipna Pharmachem - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 7Th July, 2025

    2 Jul 2025, 7:58PM Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and

Key fundamentals

Evaluate the intrinsic value of Dipna Pharmachem Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 55.7156 56.9637 40.2656 11.9274 12.9981
Liabilities 55.7156 56.9637 40.2656 11.9274 12.9981
Equity 24.0453 24.0453 11.97 0.035 0.035
Gross Profit 3.4343 3.4284 2.343 2.2444 0.3998
Net Profit 0.9741 1.0853 0.9119 1.1669 0.0242
Cash From Operating Activities -9.1946 -5.4165 -20.9762 2.8655 -2.4324
NPM(%) 0.77 0.66 0.91 1.6 0.07
Revenue 124.9171 164.3371 99.9272 72.7554 30.9999
Expenses 121.4828 160.9087 97.5841 70.511 30.6001
ROE(%) 2.59 2.89 2.43 3.11 0.06

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dipna Pharmachem Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 796.30 -0.64 72.82 12.12 301.39 0.62
Lotus Eye Hospital and Institute Ltd 123.00 1.40 402.90 44.17 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.34 0.95 0.00 91.71 -39.50 0.00
Astec Lifesciences Ltd 847.05 1.33 0.00 41.65 -604.77 0.00

Company Info

The Company was originally incorporated as "Dipan Pharmachem Private Limited` as Private Limited Company under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July19, 2011 bearing Corporate Identification Number U24100GJ2011PTC066400 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The name of the Company was changed to "Dipna Pharmachem Private Limited" and a fresh certificate of Incorporation was issued on March 29, 2012 bearing Corporate Identification Number Co. No. U24100GJ2011PTC066400by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted in to a public limited Company pursuant to a special resolution passed by the shareholders at the EGM held on May 13, 2022 and consequently the name of the Company was changed to "Dipna Pharmachem Limited" and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022. The CIN of the Company is U24100GJ2011PLC066400. 2024 -The company issued rights shares of Rs. 10 in the ratio of 13:12 at par.

The Company was originally incorporated as "Dipan Pharmachem Private Limited` as Private Limited Company under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July19, 2011 bearing Corporate Identification Number U24100GJ2011PTC066400 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The name of the Company was changed to "Dipna Pharmachem Private Limited" and a fresh certificate of Incorporation was issued on March 29, 2012 bearing Corporate Identification Number Co. No. U24100GJ2011PTC066400by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted in to a public limited Company pursuant to a special resolution passed by the shareholders at the EGM held on May 13, 2022 and consequently the name of the Company was changed to "Dipna Pharmachem Limited" and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022. The CIN of the Company is U24100GJ2011PLC066400. 2024 -The company issued rights shares of Rs. 10 in the ratio of 13:12 at par.

Read More

Parent Organisation

Dipna Pharmachem Ltd.

Founded

19/07/2011

Managing Director

Mr.Keyur Dipakkumar Shah

NSE Symbol

FAQ

The current price of Dipna Pharmachem Ltd is

The 52-week high for Dipna Pharmachem Ltd is

The market capitalization of Dipna Pharmachem Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dipna Pharmachem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dipna Pharmachem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dipna Pharmachem Ltd shares.

The CEO of Dipna Pharmachem Ltd is Mr.Keyur Dipakkumar Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT